End­points' Chi­na cov­er­age is get­ting deep­er. An­nounc­ing our part­ner­ship with Pharm­Cube, the lead­ing Chi­nese bio­phar­ma da­ta provider

Our mis­sion at End­points News is to pro­vide read­ers a com­plete pic­ture of the top drug de­vel­op­ment news of the day. And in­creas­ing­ly that means bring­ing fresh head­lines from the bio­phar­ma rev­o­lu­tion now ful­ly un­der­way in Chi­na. Which is why I’m pleased to an­nounce a joint part­ner­ship with Pharm­Cube — the lead­ing da­ta provider for the Chi­nese bio­phar­ma mar­ket.

Our col­lab­o­ra­tion fo­cus­es on two key ar­eas, play­ing to each com­pa­ny’s strength.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER